Results 71 to 80 of about 25,600 (227)

Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan [PDF]

, 2014
Background and Purpose: This study was conducted to investigate the molecular epidemiology and antimicrobial susceptibility of multidrug-resistant (MDR) Acinetobacter baumannii to three types of antibiotics.
Chang, Kai-Chih;Lin, Ming-Feng;Lin, Nien-Tsung;Wu, Wen-Jui;Kuo, Han-Yueh;Lin, Teng-Yi;Yang, Tsai-Lian;Chen, Yu-Chuan;Liou, Ming-Li
core   +1 more source

Frequency of Metallo-β-Lactamase and Antimicrobial Resistance Patterns of Acinetobacter Baumannii in Carbapenem-Resistant Isolates from Intensive Care Units of the Hospitals in Isfahan City, Iran

مجله دانشکده پزشکی اصفهان, 2015
Background: Acinetobacter baumannii is a gram-negative non-fermenting cocobacill or cocci, which is mostly found in soil, different water sources, and many healthcare environments. It is intrinsically resistance to many antibiotics.
Jina Vazirzadeh, Parisa Behshood, Leila Heidari, Hasan Ghajavand   +3 more
doaj  

Spread of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clones in patients with ventilator-associated pneumonia in an adult intensive care unit at a university hospital

Brazilian Journal of Infectious Diseases, 2015
Background: In Brazil, ventilator-associated pneumonia (VAP) caused by carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa isolates are associated with significant mortality, morbidity and costs.
Sabrina Royer, Ana Luiza Souza Faria, Liliane Miyuki Seki, Thiago Pavoni Gomes Chagas, Paola Amaral de Campos, Deivid William da Fonseca Batistão, Marise Dutra Asensi, Paulo P. Gontijo Filho, Rosineide Marques Ribas   +8 more
doaj   +1 more source

Detection of OXA‐23 Among Carbapenem‐Resistant Acinetobacter baumannii Isolated From Intensive Care Units of a Tertiary Care Hospital in Pakistan

MicrobiologyOpen, Volume 15, Issue 4, August 2026.
Graphical Abstract of the Experimental Workflow for CRAB Isolate Characterization. ABSTRACT Carbapenem‐resistant Acinetobacter baumannii (CRAB) has been designated a top‐priority critical pathogen by the World Health Organization, and the CDC has also classified it as a serious and immediate public health threat. The Cross‐sectional study was conducted
Hafsa Waseem, Ihsan Ullah, Shahzad Ahmad, Irfan Ali Mirza, Benish Aleem, Shazia Iqbal   +5 more
wiley   +1 more source

Antibiofilm, Antimicrobial, and Anti‐inflammatory Potential of Rubus chamaemorus Rhizome, Leaf, and Fruit Extracts

Chemistry &Biodiversity, Volume 23, Issue 7, July 2026.
Rhizome, leaf, and fruit extracts of cloudberry (Rubus chamaemorus L., Rosaceae) are systematically evaluated for biological activities relevant to wound infections. The methanolic leaf extract exhibits potent antibiofilm and anti‐inflammatory activity without cytotoxicity, whereas rhizome and fruit extracts are largely inactive.
Hildegard Kieninger, Stefanie Koenig, Nadin Schultze, Ulrike Garscha, Sebastian Guenther, Christian Schulze   +5 more
wiley   +1 more source

Risk factors associated with the exposure of neonates to acinetobacters through the ingestion of infant formula in NICUs [PDF]

, 2011
Acinetobacter is gaining importance as a pathogen in intensive care units (ICUs) due to the numerous outbreaks reported and the severity of the infections caused.
Juma, NAH
core  

Molecular epidemiology of Acinetobacter baumannii during COVID-19 at a hospital in northern China

Annals of Clinical Microbiology and Antimicrobials
Background The wide spread of carbapenem-resistance clones of Acinetobacter baumannii has made it a global public problem. Some studies have shown that the prevalence of Acinetobacter baumannii clones can change over time.
Xinlin Huang, Nianzhi Ning, Deyu Li, Suming Chen, Liangyan Zhang, Huan Wang, Chunmei Bao, Xiaolan Yang, Boan Li, Hui Wang   +9 more
doaj   +1 more source

Antibacterial Therapy Options for Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

Антибиотики и Химиотерапия
The review presents current treatment regimens for infections associated with carbapenem-resistant Acinetobacter baumannii, which are leading nosocomial pathogens exhibiting multidrug resistance to available antibacterial drugs. To date, widely used beta-
A. R. Goncharova, V. V. Gostev, N. E. Goncharov, O. S. Kalinogorskaya, N. S. Gladyshev   +4 more
doaj   +1 more source

Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK Modeling

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 7, July 2026.
PBPK/PD modeling and clinical retrospective validation of intravenous polymyxin B in critically ill patients with pulmonary infection. ABSTRACT Intravenous polymyxin B (PMB) is widely used for treating drug‐resistant gram‐negative pneumonia, though its efficacy in pulmonary infections is considered limited.
Shengnan Zhang, Nan Yang, Ruwei Yang, Yuanfang Qin, Tingting Wu, Cuifang Wu, Yueliang Xie, Jingjing Liu, Chun Liu, Qi Pei   +9 more
wiley   +1 more source

Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii

Frontiers in Cellular and Infection Microbiology
Patients with severe carbapenem-resistant Acinetobacter baumannii (CRAB) infections currently face significant treatment challenges. When patients display signs of infection and the clinical suspicion of CRAB infections is high, appropriate treatment should be immediately provided. However, current treatment plans and clinical data for CRAB are limited.
Siqin Zhang, Lingfang Di, Yan Qi, Xiang Qian, Siwei Wang   +4 more
openaire   +3 more sources